…There was a different way to manage clinical trials.
The most important assets in clinical development are people. It’s by understanding and living in their world – and taking great care of them – that we gain the participation and insight we need to create the best medicines and treatments.
We have created Gather™, a collaborative, end-to-end system that effortlessly supports patients, sites and sponsors throughout the clinical journey. Giving everybody the help they need, providing sites with tools to easily monitor and support patients, and providing sponsors with more accurate feedback, all in real time.
Redefining the clinical Journey
Many clinical trial processes were established before the digital technology revolution, meaning these processes are now out-dated.
We have developed Gather™ to address these issues through engaging all stakeholders in the clinical trial journey. Covering everything from recruitment to study close, patient involvement to site management, Gather™ provides seamless connections, bringing people together to gather the evidence needed to draw insights into new medicines and treatments.
Complete Product Suite
The Gather™ product suite is built upon our secure, scalable infrastructure, utilizing our patented mDNA® technology to optimise the user interface whilst ensuring personally identifiable information (PII) is protected, and a rules engine to examine data & create actions based on pre-set rules.
We’ve mapped every part of the clinical development process within Gather™, using a modular approach to simply switch functionality on as each project requires. This results in an easy to deploy, validated and robust solution to managing the patient journey during clinical trials.
Device Inclusive Approach
How does it work?
Is this your device?
Try it yourself
Exco InTouch believe that the protection of all patient data is of vital importance and that is why, since our inception, we have focused heavily on compliance with global data regulations, including FDA, HIPAA (Health Insurance Portability and Accountability Act) and EU data privacy directives. Using our mDNA® technology we are able to offer secure global mobile services in even the most complex and ever-changing landscapes.
We have integrated FDA, HIPAA and Federal Communications Commission (FCC) controls into our technology and associated processes, and Quality Management System (QMS) procedures to ensure the highest level of protection for patients. HIPAA-specific controls include, but are not limited to, encrypting data in the database at 256 bits, controlling access to and distribution of data, ongoing security monitoring, production server log storage for a minimum of 7 years and monthly executive HIPAA compliance reports.